Form 4: Charles River Laboratories Director George Massaro Sells Shares Under 10b5-1 Trading Plan

Director George Massaro of Charles River Laboratories sold common stock in multiple transactions on May 15, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On May 15, 2025, George Massaro, a director at Charles River Laboratories International, Inc., sold shares of common stock.
• The sales were executed in multiple transactions at varying prices.
• A total of 35 shares were sold at a weighted average price of $136.32.
• An additional 81 shares were sold at a weighted average price of $137.68.
• Finally, 24 shares were sold at a weighted average price of $139.05.
• These sales were conducted under a 10b5-1 trading plan adopted on August 19, 2024.
• Following these transactions, Massaro directly owns 5,575 shares of Charles River Laboratories common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing reflects routine trading activity by a company insider and is a common occurrence in publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.

Key Dates

Keywords

Form 4, Charles River Laboratories, CRL, George Massaro, Stock Sale, Director, 10b5-1 Trading Plan, Beneficial Ownership